# Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

> **NCT03451110** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 50 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** lemborexant
- **DRUG:** Loestrin
- **DRUG:** famotidine
- **DRUG:** fluconazole

## Key facts

- **NCT ID:** NCT03451110
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-03-23
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451110, "Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03451110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*